JPY 2388.0
(0.55%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 76.46 Billion JPY | 5.51% |
2022 | 72.46 Billion JPY | 4.52% |
2021 | 69.33 Billion JPY | -0.78% |
2020 | 69.87 Billion JPY | 1.05% |
2019 | 69.15 Billion JPY | -3.53% |
2018 | 71.68 Billion JPY | 2.14% |
2017 | 70.18 Billion JPY | 2.04% |
2016 | 68.78 Billion JPY | -0.39% |
2015 | 69.05 Billion JPY | 0.63% |
2014 | 68.62 Billion JPY | -0.02% |
2013 | 68.64 Billion JPY | -4.46% |
2012 | 71.84 Billion JPY | 16.77% |
2011 | 61.52 Billion JPY | 3.49% |
2010 | 59.45 Billion JPY | -6.56% |
2009 | 63.62 Billion JPY | -0.41% |
2008 | 63.89 Billion JPY | -2.44% |
2007 | 65.49 Billion JPY | -3.89% |
2006 | 68.14 Billion JPY | -4.95% |
2005 | 71.68 Billion JPY | -4.64% |
2004 | 75.17 Billion JPY | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 76.9 Billion JPY | 0.59% |
2023 Q4 | 76.46 Billion JPY | -1.61% |
2023 Q3 | 77.7 Billion JPY | 1.88% |
2023 FY | 76.46 Billion JPY | 5.51% |
2023 Q2 | 76.27 Billion JPY | 2.04% |
2023 Q1 | 74.74 Billion JPY | 3.15% |
2022 Q1 | 71.47 Billion JPY | 3.09% |
2022 Q4 | 72.46 Billion JPY | -0.72% |
2022 FY | 72.46 Billion JPY | 4.52% |
2022 Q3 | 72.99 Billion JPY | 2.44% |
2022 Q2 | 71.25 Billion JPY | -0.31% |
2021 Q3 | 70.95 Billion JPY | 0.54% |
2021 Q1 | 69.68 Billion JPY | -0.27% |
2021 Q2 | 70.57 Billion JPY | 1.28% |
2021 Q4 | 69.33 Billion JPY | -2.28% |
2021 FY | 69.33 Billion JPY | -0.78% |
2020 Q1 | 69.8 Billion JPY | 0.95% |
2020 Q4 | 69.87 Billion JPY | -3.18% |
2020 FY | 69.87 Billion JPY | 1.05% |
2020 Q3 | 72.17 Billion JPY | 1.5% |
2020 Q2 | 71.1 Billion JPY | 1.86% |
2019 Q4 | 69.15 Billion JPY | -3.57% |
2019 FY | 69.15 Billion JPY | -3.53% |
2019 Q1 | 71.15 Billion JPY | -0.74% |
2019 Q3 | 71.71 Billion JPY | 2.34% |
2019 Q2 | 70.07 Billion JPY | -1.52% |
2018 FY | 71.68 Billion JPY | 2.14% |
2018 Q1 | 71.39 Billion JPY | 1.72% |
2018 Q2 | 72.92 Billion JPY | 2.14% |
2018 Q3 | 72.74 Billion JPY | -0.24% |
2018 Q4 | 71.68 Billion JPY | -1.45% |
2017 FY | 70.18 Billion JPY | 2.04% |
2017 Q4 | 70.18 Billion JPY | -1.19% |
2017 Q3 | 71.03 Billion JPY | 0.13% |
2017 Q2 | 70.93 Billion JPY | 2.1% |
2017 Q1 | 69.48 Billion JPY | 1.01% |
2016 Q3 | 71.26 Billion JPY | 1.87% |
2016 Q1 | 70.66 Billion JPY | 2.33% |
2016 Q2 | 69.95 Billion JPY | -1.0% |
2016 FY | 68.78 Billion JPY | -0.39% |
2016 Q4 | 68.78 Billion JPY | -3.48% |
2015 Q2 | 72.21 Billion JPY | 4.61% |
2015 Q3 | 72.85 Billion JPY | 0.89% |
2015 Q4 | 69.05 Billion JPY | -5.22% |
2015 Q1 | 69.03 Billion JPY | 0.59% |
2015 FY | 69.05 Billion JPY | 0.63% |
2014 Q2 | 70.57 Billion JPY | 0.87% |
2014 Q3 | 70.35 Billion JPY | -0.31% |
2014 FY | 68.62 Billion JPY | -0.02% |
2014 Q1 | 69.96 Billion JPY | 1.93% |
2014 Q4 | 68.62 Billion JPY | -2.46% |
2013 FY | 68.64 Billion JPY | -4.46% |
2013 Q4 | 68.64 Billion JPY | -2.07% |
2013 Q1 | 69.78 Billion JPY | -2.87% |
2013 Q2 | 70.39 Billion JPY | 0.87% |
2013 Q3 | 70.09 Billion JPY | -0.42% |
2012 Q3 | 71.72 Billion JPY | 9.42% |
2012 Q4 | 71.84 Billion JPY | 0.17% |
2012 Q2 | 65.55 Billion JPY | 2.38% |
2012 Q1 | 64.02 Billion JPY | 4.06% |
2012 FY | 71.84 Billion JPY | 16.77% |
2011 Q3 | 63.37 Billion JPY | 1.06% |
2011 FY | 61.52 Billion JPY | 3.49% |
2011 Q1 | 59.34 Billion JPY | -0.17% |
2011 Q2 | 62.7 Billion JPY | 5.66% |
2011 Q4 | 61.52 Billion JPY | -2.91% |
2010 Q3 | 63.02 Billion JPY | -1.17% |
2010 Q1 | 63.51 Billion JPY | -0.17% |
2010 FY | 59.45 Billion JPY | -6.56% |
2010 Q4 | 59.45 Billion JPY | -5.67% |
2010 Q2 | 63.77 Billion JPY | 0.41% |
2009 Q3 | 64.79 Billion JPY | 0.44% |
2009 Q4 | 63.62 Billion JPY | -1.81% |
2009 Q2 | 64.51 Billion JPY | 0.0% |
2009 FY | 63.62 Billion JPY | -0.41% |
2008 Q4 | 63.89 Billion JPY | -3.85% |
2008 FY | 63.89 Billion JPY | -2.44% |
2008 Q3 | 66.45 Billion JPY | 0.0% |
2007 FY | 65.49 Billion JPY | -3.89% |
2006 FY | 68.14 Billion JPY | -4.95% |
2005 FY | 71.68 Billion JPY | -4.64% |
2004 FY | 75.17 Billion JPY | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 36.57 Billion JPY | -109.061% |
Takeda Pharmaceutical Company Limited | 15108.79 Billion JPY | 99.494% |
Sumitomo Pharma Co., Ltd. | 907.5 Billion JPY | 91.575% |
Shionogi & Co., Ltd. | 1416.91 Billion JPY | 94.604% |
Wakamoto Pharmaceutical Co.,Ltd. | 15.42 Billion JPY | -395.816% |
Nippon Shinyaku Co., Ltd. | 263.4 Billion JPY | 70.972% |
Kaken Pharmaceutical Co., Ltd. | 171.62 Billion JPY | 55.449% |
Eisai Co., Ltd. | 1393.79 Billion JPY | 94.514% |
Morishita Jintan Co., Ltd. | 17.18 Billion JPY | -344.975% |
Hisamitsu Pharmaceutical Co., Inc. | 328.77 Billion JPY | 76.744% |
Mochida Pharmaceutical Co., Ltd. | 158.8 Billion JPY | 51.851% |
Nippon Chemiphar Co., Ltd. | 49.54 Billion JPY | -54.315% |
Tsumura & Co. | 428.25 Billion JPY | 82.146% |
Kissei Pharmaceutical Co., Ltd. | 260.92 Billion JPY | 70.697% |
Torii Pharmaceutical Co., Ltd. | 133.43 Billion JPY | 42.697% |
Towa Pharmaceutical Co., Ltd. | 430.65 Billion JPY | 82.246% |
Fuji Pharma Co., Ltd. | 85.33 Billion JPY | 10.397% |
Zeria Pharmaceutical Co., Ltd. | 150.53 Billion JPY | 49.207% |
KYORIN Holdings, Inc. | 177.67 Billion JPY | 56.967% |
Taiko Pharmaceutical Co.,Ltd. | 15.04 Billion JPY | -408.175% |
Daito Pharmaceutical Co.,Ltd. | 77.7 Billion JPY | 1.606% |
SymBio Pharmaceuticals Limited | 15.35 Billion JPY | -398.044% |
MedRx Co., Ltd | 2.05 Billion JPY | -3626.121% |
Mizuho Medy Co.,Ltd. | 18.94 Billion JPY | -303.518% |
Solasia Pharma K.K. | 2.55 Billion JPY | -2898.431% |
Modalis Therapeutics Corporation | 2.02 Billion JPY | -3674.079% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 93.31 Billion JPY | 18.06% |
Sawai Group Holdings Co., Ltd. | 382.02 Billion JPY | 79.986% |
Cyfuse Biomedical K.K. | 4.21 Billion JPY | -1714.08% |
Toho Holdings Co., Ltd. | 773.42 Billion JPY | 90.114% |
Koa Shoji Holdings Co.,Ltd. | 32 Billion JPY | -138.908% |